Vitamin B6 metabolism influences the intracellular accumulation of cisplatin

References

• Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 2007; 7:573 - 84; http://dx.doi.org/10.1038/nrc2167; PMID: 17625587
   PubMed Web of Science ®Google Scholar
• Winter C, Albers P. Testicular germ cell tumors: pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 2011; 7:43 - 53; http://dx.doi.org/10.1038/nrendo.2010.196; PMID: 21116298
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, et al. Molecular mechanisms of cisplatin resistance. Oncogene 2012; 31:1869 - 83; http://dx.doi.org/10.1038/onc.2011.384; PMID: 21892204
   PubMed Web of Science ®Google Scholar
• Köberle B, Tomicic MT, Usanova S, Kaina B. Cisplatin resistance: preclinical findings and clinical implications. Biochim Biophys Acta 2010; 1806:172 - 82; PMID: 20647037
   PubMed Web of Science ®Google Scholar
• Carrassa L, Broggini M, Erba E, Damia G. Chk1, but not Chk2, is involved in the cellular response to DNA damaging agents: differential activity in cells expressing or not p53. Cell Cycle 2004; 3:1177 - 81; http://dx.doi.org/10.4161/cc.3.9.1080; PMID: 15326376
   PubMed Web of Science ®Google Scholar
• Nardella C, Clohessy JG, Alimonti A, Pandolfi PP. Pro-senescence therapy for cancer treatment. Nat Rev Cancer 2011; 11:503 - 11; http://dx.doi.org/10.1038/nrc3057; PMID: 21701512
   PubMed Web of Science ®Google Scholar
• Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007; 87:99 - 163; http://dx.doi.org/10.1152/physrev.00013.2006; PMID: 17237344
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012; 19:107 - 20; http://dx.doi.org/10.1038/cdd.2011.96; PMID: 21760595
   PubMed Web of Science ®Google Scholar
• Mandic A, Hansson J, Linder S, Shoshan MC. Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling. J Biol Chem 2003; 278:9100 - 6; http://dx.doi.org/10.1074/jbc.M210284200; PMID: 12509415
   PubMed Web of Science ®Google Scholar
• Berndtsson M, Hägg M, Panaretakis T, Havelka AM, Shoshan MC, Linder S. Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA. Int J Cancer 2007; 120:175 - 80; http://dx.doi.org/10.1002/ijc.22132; PMID: 17044026
   PubMed Web of Science ®Google Scholar
• Gonzalez VM, Fuertes MA, Alonso C, Perez JM. Is cisplatin-induced cell death always produced by apoptosis?. Mol Pharmacol 2001; 59:657 - 63; PMID: 11259608
   PubMed Web of Science ®Google Scholar
• Shulga N, Wilson-Smith R, Pastorino JG. Hexokinase II detachment from the mitochondria potentiates cisplatin induced cytotoxicity through a caspase-2 dependent mechanism. Cell Cycle 2009; 8:3355 - 64; http://dx.doi.org/10.4161/cc.8.20.9853; PMID: 19770592
   PubMed Web of Science ®Google Scholar
• Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 2010; 11:700 - 14; http://dx.doi.org/10.1038/nrm2970; PMID: 20823910
   PubMed Web of Science ®Google Scholar
• Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 2003; 22:7265 - 79; http://dx.doi.org/10.1038/sj.onc.1206933; PMID: 14576837
   PubMed Web of Science ®Google Scholar
• Borst P, Rottenberg S, Jonkers J. How do real tumors become resistant to cisplatin?. Cell Cycle 2008; 7:1353 - 9; http://dx.doi.org/10.4161/cc.7.10.5930; PMID: 18418074
   PubMed Web of Science ®Google Scholar
• Beers MH. Lung carcinoma. In: Porter RS, Jones TV, eds. The Merck manual of diagnosis and therapy. Rahway: Merck & Co., Inc., 2008:2992.
   Google Scholar
• Jemal A, Thun MJ, Ries LA, Howe HL, Weir HK, Center MM, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 2008; 100:1672 - 94; http://dx.doi.org/10.1093/jnci/djn389; PMID: 19033571
   PubMed Web of Science ®Google Scholar
• Panaretakis T. Cisplatin-induced apoptosis and development of resistance are transcriptionally distinct processes. Cell Cycle 2012; 11:3723; http://dx.doi.org/10.4161/cc.22114; PMID: 22983001
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Vitale I, Senovilla L, Olaussen KA, Pinna G, Eisenberg T, et al. Prognostic impact of vitamin B6 metabolism in lung cancer. Cell Rep 2012; 2:257 - 69; http://dx.doi.org/10.1016/j.celrep.2012.06.017; PMID: 22854025
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Vitale I, Senovilla L, Eisenberg T, Carmona-Gutierrez D, Vacchelli E, et al. Independent transcriptional reprogramming and apoptosis induction by cisplatin. Cell Cycle 2012; 11:3472 - 80; http://dx.doi.org/10.4161/cc.21789; PMID: 22918244
   PubMed Web of Science ®Google Scholar
• Yao Z, Szabadkai G. Transcriptional profiling of apoptosis: cell death classification moves toward the systems era. Cell Cycle 2012; 11:3721 - 2; http://dx.doi.org/10.4161/cc.22116; PMID: 22982998
   PubMed Web of Science ®Google Scholar
• Park SA, Choi KS, Bang JH, Huh K, Kim SU. Cisplatin-induced apoptotic cell death in mouse hybrid neurons is blocked by antioxidants through suppression of cisplatin-mediated accumulation of p53 but not of Fas/Fas ligand. J Neurochem 2000; 75:946 - 53; http://dx.doi.org/10.1046/j.1471-4159.2000.0750946.x; PMID: 10936175
   PubMed Web of Science ®Google Scholar
• Previati M, Lanzoni I, Corbacella E, Magosso S, Guaran V, Martini A, et al. Cisplatin-induced apoptosis in human promyelocytic leukemia cells. Int J Mol Med 2006; 18:511 - 6; PMID: 16865238
   PubMed Web of Science ®Google Scholar
• Tajeddine N, Galluzzi L, Kepp O, Hangen E, Morselli E, Senovilla L, et al. Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death. Oncogene 2008; 27:4221 - 32; http://dx.doi.org/10.1038/onc.2008.63; PMID: 18362892
   PubMed Web of Science ®Google Scholar
• Lavin MF, Kozlov S. ATM activation and DNA damage response. Cell Cycle 2007; 6:931 - 42; http://dx.doi.org/10.4161/cc.6.8.4180; PMID: 17457059
   PubMed Web of Science ®Google Scholar
• DeMicco A, Bassing CH. Deciphering the DNA damage histone code. Cell Cycle 2010; 9:3845; http://dx.doi.org/10.4161/cc.9.19.13381; PMID: 20948284
   PubMed Web of Science ®Google Scholar
• MacLaine NJ, Hupp TR. How phosphorylation controls p53. Cell Cycle 2011; 10:916 - 21; http://dx.doi.org/10.4161/cc.10.6.15076; PMID: 21350334
   PubMed Web of Science ®Google Scholar
• Yoshida M, Khokhar AR, Siddik ZH. Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines. Cancer Res 1994; 54:3468 - 73; PMID: 8012968
   PubMed Web of Science ®Google Scholar
• Ishida S, McCormick F, Smith-McCune K, Hanahan D. Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator. Cancer Cell 2010; 17:574 - 83; http://dx.doi.org/10.1016/j.ccr.2010.04.011; PMID: 20541702
   PubMed Web of Science ®Google Scholar
• Holzer AK, Howell SB. The internalization and degradation of human copper transporter 1 following cisplatin exposure. Cancer Res 2006; 66:10944 - 52; http://dx.doi.org/10.1158/0008-5472.CAN-06-1710; PMID: 17108132
   PubMed Web of Science ®Google Scholar
• Ishida S, Lee J, Thiele DJ, Herskowitz I. Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc Natl Acad Sci USA 2002; 99:14298 - 302; http://dx.doi.org/10.1073/pnas.162491399; PMID: 12370430
   PubMed Web of Science ®Google Scholar
• Katano K, Kondo A, Safaei R, Holzer A, Samimi G, Mishima M, et al. Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper. Cancer Res 2002; 62:6559 - 65; PMID: 12438251
   PubMed Web of Science ®Google Scholar
• Komatsu M, Sumizawa T, Mutoh M, Chen ZS, Terada K, Furukawa T, et al. Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance. Cancer Res 2000; 60:1312 - 6; PMID: 10728692
   PubMed Web of Science ®Google Scholar
• Zischka H, Lichtmannegger J, Schmitt S, Jägemann N, Schulz S, Wartini D, et al. Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease. J Clin Invest 2011; 121:1508 - 18; http://dx.doi.org/10.1172/JCI45401; PMID: 21364284
   PubMed Web of Science ®Google Scholar
• Safaei R. Role of copper transporters in the uptake and efflux of platinum containing drugs. Cancer Lett 2006; 234:34 - 9; http://dx.doi.org/10.1016/j.canlet.2005.07.046; PMID: 16297532
   PubMed Web of Science ®Google Scholar
• Amadasi A, Bertoldi M, Contestabile R, Bettati S, Cellini B, di Salvo ML, et al. Pyridoxal 5′-phosphate enzymes as targets for therapeutic agents. Curr Med Chem 2007; 14:1291 - 324; http://dx.doi.org/10.2174/092986707780597899; PMID: 17504214
   PubMed Web of Science ®Google Scholar
• Johansson M, Relton C, Ueland PM, Vollset SE, Midttun O, Nygård O, et al. Serum B vitamin levels and risk of lung cancer. JAMA 2010; 303:2377 - 85; http://dx.doi.org/10.1001/jama.2010.808; PMID: 20551408
   PubMed Web of Science ®Google Scholar
• Larsson SC, Orsini N, Wolk A. Vitamin B6 and risk of colorectal cancer: a meta-analysis of prospective studies. JAMA 2010; 303:1077 - 83; http://dx.doi.org/10.1001/jama.2010.263; PMID: 20233826
   PubMed Web of Science ®Google Scholar
• Harris HR, Cramer DW, Vitonis AF, Depari M, Terry KL. Folate, vitamin B(6), vitamin B(12), methionine and alcohol intake in relation to ovarian cancer risk. Int J Cancer 2011; In press PMID: 21953625
   PubMed Web of Science ®Google Scholar
• de La Motte Rouge T, Galluzzi L, Olaussen KA, Zermati Y, Tasdemir E, Robert T, et al. A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib. Cancer Res 2007; 67:6253 - 62; http://dx.doi.org/10.1158/0008-5472.CAN-07-0538; PMID: 17616683
   PubMed Web of Science ®Google Scholar
• Morselli E, Maiuri MC, Markaki M, Megalou E, Pasparaki A, Palikaras K, et al. Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy. Cell Death Dis 2010; 1:e10; http://dx.doi.org/10.1038/cddis.2009.8; PMID: 21364612
   PubMed Web of Science ®Google Scholar
• Kepp O, Galluzzi L, Lipinski M, Yuan J, Kroemer G. Cell death assays for drug discovery. Nat Rev Drug Discov 2011; 10:221 - 37; http://dx.doi.org/10.1038/nrd3373; PMID: 21358741
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Morselli E, Vitale I, Kepp O, Senovilla L, Criollo A, et al. miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Cancer Res 2010; 70:1793 - 803; http://dx.doi.org/10.1158/0008-5472.CAN-09-3112; PMID: 20145152
   PubMed Web of Science ®Google Scholar
• LeRoy AF, Wehling ML, Sponseller HL, Friauf WS, Solomon RE, Dedrick RL, et al. Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry. Biochem Med 1977; 18:184 - 91; http://dx.doi.org/10.1016/0006-2944(77)90089-8; PMID: 907657
   PubMed Web of Science ®Google Scholar